❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Genetics ❭ Translational studies on solid tumours [Helland] ❭ Clinical trials ❭ IMPRESS-Norway

IMPRESS-Norway Updates/publications

 
Scroll to top

Home Dept. of Cancer Genetics Translational studies on solid tumours [Helland]

  • Group members
  • Clinical trials
    • DART
    • NIPU
    • COM-IT-2
    • MATRIX-RARE
    • IMPRESS-Norway
  • Translational studies
  • Publications
  • News

Recent publications

Hektoen HH, Tsuruda KM, Mæhlen MT, Helland Å, Andreassen BK (2026)
Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities
Br J Cancer (in press)
DOI 10.1038/s41416-026-03491-1, PubMed 42259946

Carlsen IH, Dyvik VR, Johannessen TB, Fjellanger K, Sandvik IM, Hjørnevik JV, Sulen TH, Nybø T, Hundvin JA, Pilskog SMC, Fløtten Ø, Haakensen VD, Hysing LB (2026)
Prospective evaluation and clinical outcomes of adaptive radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC)
Acta Oncol, 65, 476-484
DOI 10.2340/1651-226X.2026.45745, PubMed 42200217

Ross E, Bouissou O, Helland Å, Faxvaag A (2026)
From documentation to discovery: clinicians' perspectives on the generation, usability and standardization of real-world data
Int J Med Inform, 217, 106501
DOI 10.1016/j.ijmedinf.2026.106501, PubMed 42176598

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)